Physician profile
Peter Gemelli
NPI 1770783805
$4,309.72
in general payments reported to CMS, 2019-2025
14 companies · $82.81 in 2025
The $82.81 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $23.18 · 2021: $1,412 · 2022: $284 · 2023: $295 · 2024: $1,567 · 2025: $82.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,156 · Food and Beverage: $770 · Education: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,156.46 |
| Food and Beverage | $770.19 |
| Education | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,406.51 | 2021-2023 | Intracept |
| Si-Bone, INC. | $1,089.02 | 2024 | |
| Stryker Corporation | $543.09 | 2019 | |
| Abbott Laboratories | $518.65 | 2019-2025 | Proclaim, Eterna, Octrode |
| Curonix LLC | $360.81 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $122.55 | 2021-2023 | Synchromedii |
| Boston Scientific Corporation | $114.88 | 2024-2025 | Intracept |
| Daiichi Sankyo INC. | $42.28 | 2019 | |
| Vertos Medical, INC. | $34.32 | 2023 | Mild Device Kit |
| Abbvie INC. | $16.65 | 2022 | |
| Collegium Pharmaceutical, INC. | $15.99 | 2019 | |
| Sentynl Therapeutics, INC. | $15.65 | 2019 | |
| Radius Health, INC. | $15.04 | 2019 | |
| Merit Medical Systems INC | $14.28 | 2025 | Stabilit System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Gemelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.